TABLE 3.
Variable | n a | Resistant | Nonresistant | OR (95% Cl) | P value | Adjusted OR (95% CI) | P value |
---|---|---|---|---|---|---|---|
Age (yrs), n (%) | |||||||
>50b | 462 | 8 (1.7) | 454 (98.3) | 0.74 (0.28–1.98)e | 0.726 | 0.55 (0.08–3.32) | 0.525 |
≤50 | 623 | 8 (1.3) | 615 (98.7) | ||||
Sex, n (%) | |||||||
Female | 286 | 8 (2.79) | 278 (97.21) | 2.85 (1.06–7.65)e | 0.060 | 2.21 (0.71–6.50) | 0.147 |
Male | 799 | 8 (1.00) | 791 (99.00) | ||||
Region, n (%) | |||||||
North | 282 | 6 (2.13) | 276 (97.87) | 1.72 (0.62–4.79)c,e | 0.441 | ||
Northeast | 166 | 0 (0.00) | 166 (100.00) | 1.000 | |||
Southeast | 368 | 5 (1.36) | 363 (98.64) | 0.88 (0.30–2.56)c,f | 1.000 | ||
South | 135 | 1 (0.74) | 134 (99.26) | 0.47 (0.06–3.55)c,f | 0.708 | ||
Midwest | 134 | 4 (2.99) | 130 (97.01) | 2.41 (0.77–7.58)c,f | 0.124 | ||
Case, n (%) | |||||||
Relapse | 273 | 8 (2.93) | 265 (97.07) | 3.03 (1.13–8.16)d,e | 0.043 | 8.12 (1.35–154.86) | 0.054 |
Suspected treatment failure | 491 | 7 (1.43) | 484 (98.57) | 0.94 (0.35–2.54)d,e | 1.000 | 4.86 (0.84–91.71) | 0.141 |
New case | 321 | 1 (0.31) | 320 (99.69) | 0.16 (0.02–1.19)d,f | 0.049 | ||
Clinical form, WHO, n (%) | |||||||
Multibacillary | 942 | 16 (1.70) | 926 (98.30) | 1.000 | |||
Paucibacillary | 24 | 0 (0.00) | 24 (100.00) | ||||
Reaction, n (%) | |||||||
Yes | 389 | 6 (1.54) | 383 (98.46) | 1.11 (0.38–3.24)e | 1.000 | 0.93 (0.30–2.74) | 0.899 |
No | 577 | 8 (1.39) | 569 (98.61) |
Analysis performed only with patients with the presence of M. leprae DNA detected by PCR. Data are expressed as absolute frequency (n) and percentage (%) with tailed P values for categorical variables, chi-square test or Fisher’s exact test, and for numerical variables, Mann–Whitney U.
Cutoff at 50 years old. Variables with low variability were dropped from the multivariate analysis.
Compared to all the others in the group.
Compared to all the others in the group.
Categorical variables determined by chi-square test.
Categorical variables determined by Fisher’s exact test.